PF539 MIR-223 IS SUPPRESSED IN EXOSOMES OF PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SYNDROMES AND MAY BE A MARKER OF RESIDUAL GRANULOCYTIC-MONOCYTIC DIFFERENTIATION

Authors :: Marisa Claudia Alvarez
Ilza Iris dos Santos
Adriana S. S. Duarte
Bruno Deltreggia Benites
E. de Paula
S.O.T. Saad
Lorena Bedotti Ribeiro
Source :: HemaSphere. 3:222
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.

Subjects :: mir-223
business.industry
Myelodysplastic syndromes
Cancer research
Medicine
Hematology
business
medicine.disease
Microvesicles

Full Text Access

Tools